Sixteen patients with dementia (nine with Alzheimer's disease and seven with multi-infarct dementia) were studied with xenon-133 and hexamethyl-propyleneamine-oxime single photon emission computed tomography (SPECT). Quantification of cerebral blood flow was determined in 16 hemispheric regions of interest. Neuropsychological deficits were assessed with the Mini-Mental State Examination and the Neurobehavior Cognitive Status Examination. Alzheimer's disease patients had symmetric reduction of parietal lobe perfusion; multi-infarct dementia patients had multifocal perfusion deficits. Correlations were demonstrated between cerebral blood flow in the posterior brain regions and performance on tests of language, memory, attention, figure copying, judgment, and similarities. Alzheimer's disease patients exhibited more language impairment than multi-infarct dementia patients. SPECT promises to provide diagnostic information and data relevant to interpretation of neuropsychological deficits.
Get full access to this article
View all access options for this article.
References
1.
1. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed revised. Washington, DC, American Psychiatric Association Press, 1987.
3. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile changes in the cerebral gray matter of elderly subjects. Br J Psychiatry1968; 114:797–811.
4.
4. del Ser T, Bermejo F, Portera A, et al: Vascular dementia. A clinicopathological study. J Neurol Sci1990; 96:1–17.
6. Folstein MF, Folstein SE, McHugh PR: “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12:189–198.
7.
7. Kiernan RJ, Mueller J, Langston JW, et al: The Neurobehavioral Cognitive Status Examination: A brief but differentiated approach to cognitive assessment. Ann Intern Med1987; 107:481–485.
8.
8. Schwamm LH, Van Dyke C, Kiernan RJ, et al: The Neurobehavior Cognitive Status Examination: Comparison with the Cognitive Capacity Screening Examination and the Mini-Mental State Examination in a neurosurgical population. Ann Intern Med1987; 107:486–491.
9.
9. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology1984; 34:939–944.
10.
10. Hachinski VC, Iliff LD, Zilhka E, et al: Cerebral blood flow in dementia. Arch Neurol1975; 32:632–637.
11.
11. Goodglass H, Kaplan E: The Assessment of Aphasia and Related Disorders. Philadelphia, Lea & Febiger, 1976.
12.
12. Bonte FJ, Ross ED, Chehabi HH, et al: SPECT study of regional cerebral blood flow in Alzheimer disease. J Comput Assist Tomogr1986; 10:579–583.
13.
13. Gemmell HG, Sharp PF, Besson JAO, et al: Differential diagnosis of dementia using the cerebral blood flow agent 99mTc HM-PAO: A SPECT study. J Comput Assist Tomogr1987; 11:398–402.
14.
14. Johnson KA, Mueller ST, Walshe TM, et al: Cerebral perfusion imaging in Alzheimer's disease. Arch Neurol1987; 44:165–168.
15.
15. Perani D, Di Piero V, Vallar G, et al: Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med1988; 29:1507–1514.
16.
16. Testa HJ, Snowden JS, Neary D, et al: The use of [Tc-99]-HM-PAO in the diagnosis of primary degenerative dementia. J Cereb Blood Flow Metab1988; 8:S123–S126.
17.
17. Weinstein HC, Hijdra A, van Royen EA, et al: Determination of cerebral blood flow by SPECT: A valuable tool in the investigation of dementia?Clin Neurol Neurosurg1989; 91:13–19.
18.
18. Hier DB, Hagenlocker K, Shindler AG: Language disintegration in dementia: Effects of etiology and severity. Brain Lang1985; 25:117–133.
19.
19. Powell AL, Cummings JL, Hill MA, et al: Speech and language alterations in multi-infarct dementia. Neurology1988; 38:717–719.
20.
20. Celsis P, Agniel A, Puel M, et al: Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry1987; 50:1602–1612.
21.
21. Komatani A, Yamaguchi K, Sugai Y, et al: Assessment of demented patients by dynamic SPECT of inhaled xenon-133. J Nucl Med1988; 29:1621–1626.
22.
22. Johnson KA, Holman L, Mueller SP, et al: Single photon emission computed tomography in Alzheimer's disease. Arch Neurol1988; 45:392–396.
23.
23. Ishii N, Nishihara Y, Imamura T: Why do frontal lobe symptoms predominate in vascular dementia with lacunes?Neurology1986; 36:340–345.
24.
24. DeKosky ST, Shih W-J, Schmitt FA, et al: Assessing the utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: Correlation with cognitive severity. Alzheimer Dis Assoc Disord1990; 4:14–23.
25.
25. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry1984; 141:1356–1364.
26.
26. Goldenberg G, Podreka I, Suess E, et al: The cerebral localization of neuropsychological impairment in Alzheimer's disease: A SPECT study. J Neurol1989; 236:131–138.
27.
27. Montaldi D, Brooks DN, McColl JH, et al: Measurement of regional cerebral flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry1990; 53:33–38.
28.
28. Roth M, Tym E, Mountjoy CQ, et al: CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry1986; 149:698–709.
29.
29. Brun A, Gustafson L: Limbic lobe involvement in presenile dementia. Arch Psychiatr Nervenkr1978; 226:79–93.
30.
30. Berg EA: A simple objective technique for measuring flexibility in thinking. J Gen Psychol1948; 39:15–22.
